Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 4 I, 1999, Pages 1043-1051

  Sont, Jacob K ^d   Willems, Luuk N A ^d   Bel, Elisabeth H ^d   Van Krieken, J Han J M ^e   Vandenbroucke, Jan P ^e   Sterk, Peter J ^d   Apap, C R ^a   Roldaan, A C ^b   Van Kralingen, K W ^b   Van Klink, H C J ^c   Evertse, C E ^d   Neeskens, P ^e   Van Schadewijk, W A A M ^e   Hooijer, R ^e   Cramer, G ^e   Dijkstra, K ^e   Dijkstra, N ^e   Kluin Nelemans, J C ^e  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b T Lange Land Ziekenhuis   (Netherlands)

^c Diaconessenhuis Hospital   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; METHACHOLINE; PREDNISONE; STEROID;

ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE MARKER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG BIOPSY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0032938331     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.4.9806052     Document Type: Article

References (35)

1. National Institutes of Health, National Heart, Lung, and Blood Institute. 1995. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Publication No. 95-3695.
2. Djukanović, R., W. R. Roche, J. W. Wilson, C. R. W. Beasley, O. P. Twentyman, P. H. Howarth, and S. T. Holgate. 1990. Mucosal inflammation in asthma [State of the art]. Am. Rev. Respir. Dis. 142:434-457.
3. Roche, W. R., J. H. Williams, R. Beasley, and S. T. Holgate. 1989. Sub-epithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-524.
4. Bousquet, J., P. Chanez, and J. Y. Lacoste. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
5. Boulet, L. P., H. Turcotte, and A. Brochu. 1994. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chest 105:1024-1031.
6. Sont, J. K., J. H. J. M. van Krieken, C. E. Evertse, R. Hooijer, L. N. A. Willems, and P. J. Sterk. 1996. The relationship between the inflammatory infiltrate in bronchial biopsies and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51:496-502.
7. Lange, P., J. Parner, J. Vesbo, P. Schnohr, and G. Jensen. 1998. A 15-years follow-up study of ventilatory function adults with asthma. N. Engl. J. Mod. 339:1194-1200.
8. Woolcock, A. J. 1990. Assessment of bronchial responsiveness as a guide to prognosis and therapy in asthma. Med. Clin. North Am. 74:753-765.
9. Holgate, S. T. 1993. Asthma - past, present and future. Eur. Respir. J. 6: 1507-1520.
10. Szefler, S. J., and D. Y. M. Leung. 1996. Asthma management: past, present, and future. In S. J. Szefler and D. Y. M. Leung, editors. Severe Asthma: Pathogenesis and Clinical Management. Marcel Dekker, New York. 537-554.
11. Bradley, B. L., M. Azzawi, M. Jacobson, B. Assoufi, J. V. Collins, A. M. A. Irani, L. B. Schwartz, S. R. Durham, P. K. Jeffery, and A. B. Kay. 1991. Eosinophils, T-lymphocytes, mast cell, neutrophils, and macrophages in bronchial biopsy specimens for atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88:661-674.
12. Cockcroft, D. W. 1991. Therapy for airway inflammation in asthma. J. Allergy Clin. Immunol. 87:914-919.
13. Woolcock, A. J. 1990. Use of corticostcroids in treatment of patients with asthma. J. Allergy Clin. Immunol. 84:975-978.
14. Pattemore, P. K., and S. T. Holgate. 1993. Bronchial hyperresponsiveness and its relationship to asthma in childhood. Clin. Exp. Allergy 23: 886-900.
15. Crimi, E., A. Spanevello, M. Neri, P. W. Ind, G. A. Rossi, and V. Brusasco. 1998. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157:4-9.
16. Quanjer, Ph. H., G. J. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, and J. C. Yernault. 1993. Lung volumes and forced ventilatory flows. Eur. Respir. J. 6(Suppl. 16):S5-S40.
17. Hargreave, F. E., J. Dulovich, and M. T. Newhouse, editors. 1990. Rostrum: the assessment and treatment of asthma: a conference report. J. Allergy Clin. Immunol. 85:1098-1111.
18. Sterk, P. J., L. M. Fabbri, Ph. H. Quanjer, D. W. Cockcroft, P. M. O'Byrne, S. D. Anderson, E. F. Juniper, and J. L. Malo. 1993. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur. Respir. J. 6:S53-S83.
19. Djukanović, R., J. W. Wilson, C. K. W. Lai, S. T. Holgate, and P. H. Howarth. 1991. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am. Rev Respir. Dis. 143:772-777.
20. Workshop Summary and Guidelines. 1992. Investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airways diseases. Eur. Respir. J. 5:115-121.
21. Sont, J. K., L. N. A. Willems, C. E. Evertse, P. J. Sterk, and J. H. J. M. van Krieken. 1997. Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma. Eur. Respir. J. 10:2602-2608.
22. Altman, D. G. 1991. Practical Statistics for Medical Research. Chapman and Hall, London. 430-433.
23. Lin, D. Y., and L. J. Wei. 1989. The robust inference for the Cox proportional hazards model. J. Am. Stat. Assoc. 84:1074-1078.
24. Malo, J. L., J. Larcheveque, C. Trudeau, C. Daquino, and A. Cartier. 1993. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma? J. Allergy Clin. Immunol. 91:702-709.
25. Uwyyed, K., C. Springer, A. Avital, E. Bar-Yishay, and S. Godfrey. 1996. Home recording of PEF in young asthmatics: does it contribute to asthma management? Eur. Respir. J. 9:872-879.
26. Fishwick, D., and R. Beasley. 1996. Use of peak flow-based self-management plans by adult asthmatic patients. Eur. Respir. J. 9:861-865.
27. Cockcroft, D. W., and V. A. Swystun. 1996. Asthma control versus asthma severity. J. Allergy Clin. Immunol. 98:1016-1018.
28. Trigg, C. J., N. D. Manolitsas, J. H. Wang, M. A. Calderon, A. Mcaulay, S. E. Jordan, M. J. Herdman, N. Jhalli, J. M. Duddle, S. A. Hamilton, J. L. Devalia, and R. J. Davies. 1994. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 150:17-22.
29. Jeffery, P. K., R. W. Godfrey, E. Adelroth, F. Nelson, A. Rogers, and S. A. Johansson. 1992. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am. Rev. Respir. Dis. 145:890-899.
30. Haley, K. J., and J. M. Drazen. 1998. Inflammation and airway function in asthma: what you see is not necessarily what you get. Am. J. Respir. Crit. Care Med. 157:1-3.
31. Olivieri, D., A. Chetta, M. Del Donno, G. Bertorelli, A. Casalini, A. Pesci, R. Testi, and A. Foresi. 1997. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am. J. Respir. Crit. Care Med. 155:1864-1871.
32. Chetta, A., A. Foresi, M. Del Donno, G. Bertorelli, A. Pesci, and D. Olivieri. 1997. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111:852-857.
33. Kamada, A. K., S. J. Szefler, R. J. Martin, H. A. Boushey, V. M. Chinchilli, J. M. Drazen, J. E. Fish, E. Israel, S. C. Lazarus, and R. F. Lemanske. 1996. Issues in the use of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 153:1739-1748.
34. Haahtela, T., M. Järvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, O. Selroos, A. Sovijärvi, B. Stenius-Aarniala, T. Svahn, R. Tammivaara, and L. A. Laitinen. 1994. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.
35. in 't Veen, J. C. C. M., H. W. F. M. de Gouw, H. H. Smits, J. K. Sont, P. S. Hiemstra, P. J. Sterk, and E. H. Bel. 1996. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur. Respir. J. 9:2441-2447.